Author: bbc.com

In April 2026, uniQure announced plans to seek UK regulatory approval for AMT-130, its gene therapy for Huntington’s disease, supported by Phase 1/2 data indicating a very large slowing of disease progression at the high dose. The company also aims to meet the US FDA to discuss a potential Phase 3 trial, highlighting how AMT-130 is moving closer to a possible first-in-class treatment pathway for this rare neurodegenerative disorder. We’ll now examine how this move toward UK approval for…Read More

Read More

Shamir Chandran, a cancer specialist doctor of Indian origin, has been banned from practicing medicine in Britain. He was convicted of controlling behavior and cruelty. The Medical Practitioners Tribunal Service removed him from the medical register. Chandran reportedly left the UK before the proceedings concluded. He stated he would never work in Britain again.Read More

Read More

Global Ship Lease (GSL) just posted first quarter 2026 results that topped analyst expectations, with both revenue and earnings per share ahead of forecasts, alongside full 2026 charter coverage and ongoing dividend payments. See our latest analysis for Global Ship Lease. Despite the Q1 beat and firm charter coverage, the share price fell 7.1% on the day of the results and is down over the past quarter. However, the 1 year total shareholder return of 66.2% and 3 year total shareholder return…Read More

Read More